|  | 
|  | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.United States | 
| First Approval Date09 Jan 1979 | 
|  | 
|  | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhaseDiscontinued | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
|  | 
| MechanismGABAA receptor antagonists | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhaseDiscontinued | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with Pharmacia & Upjohn Co., Inc.
0  Patents (Medical) associated with Pharmacia & Upjohn Co., Inc.
100 Deals associated with Pharmacia & Upjohn Co., Inc.
100 Translational Medicine associated with Pharmacia & Upjohn Co., Inc.